Skip to content
OpenCapital
Get started

Utah Medical Products UTMD Accounts Receivable

Discontinued — last reported Q2 '26

Accounts Receivable at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$2.21B-27.2%
TFX
TeleflexTFX
$365.53M-21.3%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$809.2M+3.6%
IAR
Integra LifeSciencesIART
$267.19M-6.1%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$206.45M+3.5%
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
$224.8M-7.3%

Other financials

Income statement

See full
Revenue$8.5M-14.3%
Gross profit$4.8M-15.0%
Operating income$2.6M-17.1%
Net income$2.7M-11.9%
EPS (diluted)$0.84-10.2%

Balance sheet

See full
Cash & equivalents$87.5M+6.5%
Total debt$210.0K—
Total equity$122.0M+3.8%
Total assets$124.6M+3.1%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$225.94M+24.5%
P/E21.6×+7.1×
P/S6.3×+1.6×

Profitability

See full
Gross margin57.9%+0.6pp
Operating margin28.4%-4.1pp
Net margin29%-3.3pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity8.8%-1.6pp
Debt / equity0×—
Current ratio48.6×+6.7×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: Utah Medical Products’s 8-K, filed July 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's accounts receivable?
Utah Medical Products (UTMD) reported accounts receivable of $3.57M in Q2 2026.
How has Utah Medical Products's accounts receivable changed year-over-year?
Utah Medical Products's accounts receivable decreased by 1.8% year-over-year, from $3.63M to $3.57M.
What is the long-term trend for Utah Medical Products's accounts receivable?
Over 4 years (2021 to 2025), Utah Medical Products's accounts receivable has grown at a -5.8% compound annual growth rate (CAGR), from $18.79M to $14.82M.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.